SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-153365
Filing Date
2021-05-06
Accepted
2021-05-06 16:35:27
Documents
57
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d145644d10q.htm   iXBRL 10-Q 1229625
2 EX-31.1 d145644dex311.htm EX-31.1 6099
3 EX-31.2 d145644dex312.htm EX-31.2 6041
4 EX-32.1 d145644dex321.htm EX-32.1 4480
  Complete submission text file 0001193125-21-153365.txt   4668032

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ziop-20210331.xsd EX-101.SCH 46591
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ziop-20210331_cal.xml EX-101.CAL 23870
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ziop-20210331_def.xml EX-101.DEF 249270
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20210331_lab.xml EX-101.LAB 354025
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20210331_pre.xml EX-101.PRE 304935
10 EXTRACTED XBRL INSTANCE DOCUMENT d145644d10q_htm.xml XML 491836
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 21898450
SIC: 2834 Pharmaceutical Preparations